Patent goon squad
The general idea would be for scientists (who might be so inclined) to actively keep an eye on new patent applications in their fields of interest in order to push back on overly-broad patents. I think there would be an interest in this sort of thing for synthetic biology at a minimum, but the feasibility is an open question :)
- Sign up for the Synthetic Biology Patent RSS feed !
- The search terms were kindly provided by Paul Oldham.
- Jason R. Kelly:In my experience is has a pretty good signal to noise ratio for catching SB patents.
Contentious Patent Applications
It might be an idea to post important patents and allow people to add prior art that they might know about.
Does anybody have suggestions for categories for synthetic biology patents? The patents that are posted now seem to fit into 'devices' and 'assembly'. If we could organize the patents into particular technology categories, we could then create an internal hierarchy of patents based on the breadth of the claims.
Jason R. Kelly: Well, we could just get a laundry list together, some are probably sub-categories of others. Also, we probably care about certain categories more than others.
- Devices - one or more biological parts that accomplish a specific function
- Chassis - organisms for operating synthetic systems
- Assembly - how to put parts together
- Synthesis - how to synthesize DNA de novo
- Part collections/libraries - the idea of collecting (and QCing?) parts
This seems to be difficult one...we need to define some search terms to find what we are looking for. Actually, identifying useful search parameters for all categories is a good idea
These are the patents over which Codon Devices Inc. is suing Blue Heron Biotechnology (links are press releases from each respective company).
- US patent application 2006/281113 date May 18, 2005
- Some of the claims seem obvious to me such as using linker oligos to assemble parts together
Invitrogen Gateway cloning system
This is potentially an example of a cloning standard that is under proprietary control. However, Invitrogen has an open licensing policy (have not read the details).
According to Invitrogen, Gateway® Cloning Products and their use are the subject of one or more of U.S. Patent Nos. 5,888,732, 6,143,557, 6,171,861, 6,270,969, 6,277,608, and 6,720,140 and/or other pending U.S. and foreign patent applications owned by Invitrogen Corporation.
Prior Art (pre June 5,2003)
Weiss & Knight 1999 - see fig 1, a biological inverter based on gene expression.
Please add/edit -- or answer!
- How hard is it to filter patents via existing search tools (e.g. into sub-fields)?
- What is the number of 'biology' patent applications submitted each day?
- Can you get access to the applications early enough in the process to effect the outcome?
- Is it better to go after existing patents (life the EFF patent busting project) or patent applications?
- Response from EFF lawyer:
It's very hard to attack patent applications because there is no formal opposition process and they often change during the prosecution process so as to be a bit of a moving target. Also, we've chosen to go after patents that are actively being used to attack; when they are at the application stage, it is harder to predict which ones will be the worst and worth going after. Good luck in your effects, though.
- Is a law background is required to actually evaluate a patent?
- Paul Oldham's suggested search terms for synthetic biology patents (Patent Lens RSS feed)
- Memo on viability of patent review squad (word doc) - This is a great evaluation of the viability of this project by Hanna Breetz from MIT's Program on Emerging Technologies (PoET).
- Patent search tools meeting
- http://www.ip.com/prior-art-database/defensive-publishing.jsp -- "Defensive publishing", where companies publish patentable things that they don't want to patent, but that they don't want anyone else to patent either.
- The US patent office sounds like it might be interested in this sort of community input (Washington Post).
- EFF Patent Busting Project - interesting parallel in the internet patent arena. EFF is digging up prior art on existing patents and then pursuing legal action for re-examination.
- Wikipatents - similar to the peer to patent process.
- Hanna Breetz, Technology and Policy Program at MIT
- Jason Kelly, BE at MIT
- Royd, CAMBIA